MADELEINE SINGER: Open Payments
NPI 1265079701 · NEW CASTLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,863 in 130 payments from 15 companies in 2025. Trend: 2023 $961 · 2024 $3,254 · 2025 $2,863
Food & beverage: $2,817Education: $47
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $583 |
| UCB, Inc. | 18 | $468 |
| LEO Pharma Inc. | 9 | $354 |
| GENZYME CORPORATION | 11 | $279 |
| Janssen Biotech, Inc. | 13 | $215 |
| Novartis Pharmaceuticals Corporation | 14 | $213 |
| Galderma Laboratories, L.P. | 9 | $199 |
| Regeneron Healthcare Solutions, Inc. | 3 | $195 |
| Amgen Inc. | 6 | $118 |
| PFIZER INC. | 5 | $83 |
Products named: Bimzelx, DUPIXENT, SKYRIZI, TREMFYA, ADBRY, NEMLUVIO, ANZUPGO, COSENTYX.
Industry payments across PA — which companies pay providers there.
